• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 159-173 of 901 results

1005 Exhibit: 1005 Declaration of William J Jusko, PhD

Document IPR2024-00631, No. 1005 Exhibit - 1005 Declaration of William J Jusko, PhD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1070 Exhibit: 1070 Boylan, Parenteral Products, in MODERN PHARMACEUTICS G...

Document IPR2024-00631, No. 1070 Exhibit - 1070 Boylan, Parenteral Products, in MODERN PHARMACEUTICS Gilbert S Banke (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1082 Exhibit: 1082 Scheduling Order, Novo Nordisk Inc v Rio Biopharmaceuticals I...

Document IPR2024-00631, No. 1082 Exhibit - 1082 Scheduling Order, Novo Nordisk Inc v Rio Biopharmaceuticals Inc, No (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1030 Exhibit: 1030 Kim, Effects of Once Weekly Dosing of a Long Acting Release F...

Document IPR2024-00631, No. 1030 Exhibit - 1030 Kim, Effects of Once Weekly Dosing of a Long Acting Release Formulatio (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1071 Exhibit: 1071 US Patent No 6,284,727

Document IPR2024-00631, No. 1071 Exhibit - 1071 US Patent No 6,284,727 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1050 Exhibit: 1050 Garber, Efficacy of Metformin in Type II Diabetes Results of a D...

Document IPR2024-00631, No. 1050 Exhibit - 1050 Garber, Efficacy of Metformin in Type II Diabetes Results of a Double (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1048 Exhibit: 1048 FDA Guidance for Industry, Exposure Response Relationships ...

Document IPR2024-00631, No. 1048 Exhibit - 1048 FDA Guidance for Industry, Exposure Response Relationships Study Desi (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1072 Exhibit: 1072 US Patent No 5,164,366

Document IPR2024-00631, No. 1072 Exhibit - 1072 US Patent No 5,164,366 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1061 Exhibit: 1061 US Patent App Pub No 20110166321

Document IPR2024-00631, No. 1061 Exhibit - 1061 US Patent App Pub No 20110166321 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1043 Exhibit: 1043 US Patent App Pub 20040102486

Document IPR2024-00631, No. 1043 Exhibit - 1043 US Patent App Pub 20040102486 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1080 Exhibit: 1080 NCT01933490, CLINICALTRIALSGOV, httpswwwclinicaltrialsgo...

Document IPR2024-00631, No. 1080 Exhibit - 1080 NCT01933490, CLINICALTRIALSGOV, httpswwwclinicaltrialsgovct2sh (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1014 Exhibit: 1014 Clinical Trial No NCT00851773

Document IPR2024-00631, No. 1014 Exhibit - 1014 Clinical Trial No NCT00851773 (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1040 Exhibit: 1040 Vilsbøll, Glucagon Like Peptide 1 and Diabetes Treatment, 21 IN...

Document IPR2024-00631, No. 1040 Exhibit - 1040 Vilsbøll, Glucagon Like Peptide 1 and Diabetes Treatment, 21 INT’L DIA (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1007 Exhibit: 1007 Declaration of Paul Dalby, PhD

Document IPR2024-00631, No. 1007 Exhibit - 1007 Declaration of Paul Dalby, PhD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze

1501 Exhibit: 1501 Declaration of Judith Korner, MD, PhD

Document IPR2024-00631, No. 1501 Exhibit - 1501 Declaration of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 11 12 13 14 15 ... >>